PATENT CLAIM ANALYSIS

Application Number: 16280512
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "252020"]

Abstract:
The disclosures herein relate to novel compounds of formula wherein R 1 , R 2 , R 3  and R 4  and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of inflammation, neurological or psychiatric disorders associated with modulating mGlu5 receptor function.

Claim (Index 13):
The compound according to  claim 12 , wherein R 1  is F, Cl or cyano.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15618504', '14904907', '15771920', '15569263', '15094687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940734729506922
- 35 USC 102 Novelty (BERT): 0.5517363583636101
- Combined Prediction Score: 0.7698397614919841
- Mean Citation Score: 328.269762
- Max Citation Score: 425.46854
- Similarity Product: 305.6506402084338

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test